Skip to main content

Table 2 Accelerometer-measured physical activity at enrollment and 12 weeks among 41 colorectal cancer survivors participating in a pilot randomized controlled trial of a Fitbit Flex and daily text messages

From: Self-monitoring and reminder text messages to increase physical activity in colorectal cancer survivors (Smart Pace): a pilot randomized controlled trial

 

Intervention (n = 20)

Control (n = 19)a

 

Type of Physical Activity

Baseline

Mean ± SD

12 Weeks

Mean ± SD

Baseline

Mean ± SD

12 Weeks

Mean ± SD

Mean difference in change in activity between groups (95% CI)

Moderate-to-vigorous, min/day

32.9 ± 17.9

46.6 ± 48.4

50.8 ± 20.7

54.5 ± 24.9

13.1 (− 13.5, 39.7)

Moderate, min/day

32.1 ± 17.6

43.5 ± 39.0

46.9 ± 18.9

51.7 ± 23.2

9.3 (−12.8, 31.3)

Vigorous, min/day

0.87 ± 0.96

3.1 ± 10.3

3.9 ± 5.2

2.8 ± 3.3

3.8 (− 1.5, 9.1)

Steps per day

9007 ± 3638

10,047 ± 4461

11,829 ± 4052

12,541 ± 5535

649 (− 1581, 2878)

  1. a12 week accelerometer data was not available from two participants in the control arm